- E88.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E88.89 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E88.89 – other international versions of ICD-10 E88.89 may differ.
ICD-10-CM E88.89 is grouped within Diagnostic Related Group(s):
- 642 Inborn and other disorders of metabolism
Applicable To
- Launois-Bensaude adenolipomatosis
Type 1 Excludes
- adult pulmonary Langerhans cell histiocytosis (J84.82)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E88.89:
- dihydropyrimidine dehydrogenase (DPD) > Deficiency, deficient
- Erdheim-Chester (ECD) > Disease, diseased
- specified NEC > metabolism NOS E88.9
- Launois-Bensaude > Lipomatosis E88.2
- symmetrical lipomas, neck > disease Q74.0
- Erdheim-Chester (ECD) > Syndrome